Waters gets China FDA approval for LC-MS for in-vitro diagnostic use

摘要

US-based analytical instrumentation major, Waters Corporation, has announced that the Chinese Food and Drug Administration (CFDA) has approved its 'Acquity UPLC I-Class IVD/Xevo TQ-S 1VD' system for in vitro diagnostic (IVD) use in China. The system was approved for clinical analysis of a variety of compounds that include diagnostic indicators and compounds for treatment monitoring.